EMAIL THIS PAGE TO A FRIEND

Oncoimmunology

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.


PMID 26155400

Abstract

There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell differentiation. Here, we found that the frequency of interleukin (IL)-22